Disclosure: This post was sponsored by Galderma Laboratories L.P. through their partnership with POPSUGAR. While I was compensated by POPSUGAR to write a post about Mirvaso, all opinions are my own, as per usual.
Guys, I’ve worked REALLY hard on my skin over the past decade (see photo above with NO MAKEUP!) and so, when new products come out that will make my skin even better, well I get pretty excited about it. Rosacea (a chronic inflammatory skin condition), for example, is a skin condition that I was diagnosed with at age 22 and I distinctly remember the conversation going a little something like this:
Me: I’ve been breaking out a lot. I think I have adult acne.
Derm: Yes, I can see that…and you’re also about to get full blown Rosacea as well.
Me: What? No. I don’t think so…my face is just red from the acne.
Derm: Right now, yes, but in a year or two, the acne will clear up and you’ll have Rosacea.
I scoffed at this crazy person…but he was right. Granted, I don’t have a terrible case AT ALL, so I’m not complaining too much; however, if I go out without a little tinted moisturizer on, people think I got a sunburn on my cheeks which, at this point, I can laugh at. Most days, when I’m not triggered, I can get away with not wearing too much makeup on my face which is why Mirvaso’s Break Up with Your Makeup contest is pretty great. It’s estimated that 15 million Americans are affected by this condition and, unfortunately, not many people know that it’s treatable and instead cake on the makeup to conceal their redness. I’m excited that Mirvaso, the only FDA-approved treatment for the persistent redness of rosacea, is hosting this sweepstakes to raise awareness of the treatment, encouraging people to Break Up with Your Makeup. Mirvaso works fast, providing same-day results that last up to 12 hours before the redness returns, leaving users “red-carpet ready”. You can check out more information, and enter to win a trip to the Emmys (in LA!) HERE.
Important Safety Information Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.